TriSalus Life Sciences's total assets for Q3 2025 were $36.46M, a decrease of -11.75% from the previous quarter. TLSI total liabilities were $63.19M for the fiscal quarter, a 4.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.